NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 118 filers reported holding NOVAVAX INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,868 | -32.6% | 5,921 | -30.9% | 0.00% | – |
| Q2 2023 | $63,645 | +85.9% | 8,566 | +73.4% | 0.00% | – |
| Q1 2023 | $34,234 | +52.4% | 4,940 | +126.1% | 0.00% | – |
| Q4 2022 | $22,462 | -54.2% | 2,185 | -17.7% | 0.00% | – |
| Q3 2022 | $49,000 | -58.1% | 2,654 | +16.9% | 0.00% | – |
| Q2 2022 | $117,000 | -24.0% | 2,270 | +9.0% | 0.00% | – |
| Q1 2022 | $154,000 | -27.0% | 2,083 | +41.8% | 0.00% | – |
| Q4 2021 | $211,000 | -49.6% | 1,469 | -27.5% | 0.00% | -100.0% |
| Q3 2021 | $419,000 | -6.7% | 2,025 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $449,000 | -48.9% | 2,118 | -56.3% | 0.00% | -50.0% |
| Q1 2021 | $879,000 | +17.5% | 4,848 | -27.7% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | +21.6% | 6,706 | +18.2% | 0.00% | +100.0% |
| Q3 2020 | $615,000 | +101.6% | 5,674 | +55.2% | 0.00% | 0.0% |
| Q2 2020 | $305,000 | +6000.0% | 3,657 | +814.2% | 0.00% | – |
| Q1 2020 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |